(19)
(11) EP 3 784 241 A1

(12)

(43) Date of publication:
03.03.2021 Bulletin 2021/09

(21) Application number: 19793407.8

(22) Date of filing: 22.04.2019
(51) International Patent Classification (IPC): 
A61K 31/4985(2006.01)
C07D 487/16(2006.01)
(86) International application number:
PCT/US2019/028432
(87) International publication number:
WO 2019/209667 (31.10.2019 Gazette 2019/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.04.2018 US 201862663377 P
30.04.2018 US 201862664527 P

(71) Applicant: Merck Sharp & Dohme Corp.
Rahway, New Jersey 07065-0907 (US)

(72) Inventors:
  • YU, Tao
    Kenilworth, New Jersey 07033 (US)
  • APGAR, James, M.
    Kenilworth, New Jersey 07033 (US)
  • WHITEHEAD, Alan
    Rahway, New Jersey 07065-0907 (US)
  • ZHANG, Yonglian
    Kenilworth, New Jersey 07033 (US)
  • HU, Zhiyong
    Kenilworth, New Jersey 07033 (US)
  • SHURTLEFF, Valerie, W.
    West Point, Pennsylvania 19486 (US)
  • MCCAULEY, John, A.
    West Point, Pennsylvania 19486 (US)
  • RAHEEM, Izzat, T.
    West Point, Pennsylvania 19486 (US)

(74) Representative: Jaap, David Robert 
MSD Hertford Road
Hoddesdon, Herts EN11 9BU
Hoddesdon, Herts EN11 9BU (GB)

   


(54) TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS